Costs of physical and mental comorbidities among employees: A comparison of those with and without bipolar disorder

Current Medical Research and Opinion

Volumn 22, Issue 3, 2006, Pages 443-452

  Rajagopalan, Krithika ^a   Kleinman, Nathan L ^b   Brook, Richard A ^c   Gardner, Harold H ^b   Brizee, Truman J ^b   Smeeding, James E ^d,e  

^a ASTRAZENECA   (United Kingdom)

^b Human Capital Management Services   (United States)

^c Retrospective Analysis   (United States)

^d JeSTARx Group   (United States)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Bipolar disorder; Comorbid conditions; Economics; Employees; Observational; Treatment costs

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DATA BASE; EMPLOYEE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PRESCRIPTION;

ADULT; BIPOLAR DISORDER; COMORBIDITY; FEMALE; HEALTH CARE COSTS; HUMANS; LOGISTIC MODELS; MALE; MENTAL DISORDERS; PREVALENCE; RETROSPECTIVE STUDIES; SICK LEAVE; STATISTICS, NONPARAMETRIC; UNITED STATES; UTILIZATION REVIEW;

EID: 33645234658     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X89748     Document Type: Article

References (45)

1. Griswold KS, Pessar LF. Management of bipolar disorder. Am Fam Physician 2000;62:1343-53, 1357-8
2. Kleinman L, Lowin A, Flood E, et al. Costs of bipolar disorder. Pharmacoeconomics 2003;21:601-22
3. Thase ME, Sachs GS. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry 2000;48:558-72
4. Dion GL, Tohen M, Anthony WA, et al. Symptoms and functioning of patients with bipolar disorder six months after hospitalisation. Hosp Community Psychiatry 1988;39:652-7
5. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry 2000;61(Supp 13):38-41
6. Freeman MP, Freeman SA, McElroy SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord 2002;68:1-23
7. McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001;158:420-6
8. Barbato N, Hafner RJ. Comorbidity of bipolar and personality disorder. Aust NZJ Psychiatry 1998;32:276-80
9. Sherwood Brown E, Suppes T, Adinoff B, et al. Drug abuse and bipolar disorder: comorbidity or misdiagnosis? J Affect Disord 2001;65:105-15
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington DC: American Psychiatric Association, 1994
11. Dunayevich E, Sax KW, Keck PE Jr, et al. Twelve-month outcome in bipolar patients with and without personality disorders. J Clin Psychiatry 2000;61:134-9
12. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005;67:1-8
13. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156:1417-20
14. Regenold WT, Thapar RK, Marano C, et al. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J Affect Disord 2002;70:19-26
15. Ruzickova M, Slaney C, Garnham J, Aida M. Clinical features of bipolar disorder with and without comorbid diabetes mellitus. Can J Psychiatry 2003;48:458-61
16. McElroy SL, Frye MA, Suppes T, et al. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry 2002;63:207-13
17. Keck PE, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy- associated weight gain. J Clin Psychiatry 2003;64: 1426-35
18. Brook RA, Rajagopalan K, Kleinman NL, et al. Incurring greater health care costs: risk stratification of bipolar disorder employees. Prim Care Companion J Clin Psychiatry 2006;8(1):in press
19. Kleinman NL, Brook RA, Rajagopalan K, et al. Lost time, absence costs, and reduced productivity output for employees with bipolar disorder. J Occup Environ Med 2005;47:1117-24
20. Bowden CL. Treatment options for bipolar depression. J Clin Psychiatry 2005;66(Suppl 1):3-6
21. Stave GM, Muchmore L, Gardner HH. Quantifiable impact of the contract for health and wellness: health behaviors, health care costs, disability, and workers' compensation. J Occup Environ Med 2003;45:109-17
22. Muchmore L, Lynch WD, Gardner HH, et al. Prevalence of arthritis and associated joint disorders in an employed population and the associated healthcare, sick leave, disability, and workers' compensation benefits cost and productivity loss for employers. J Occup Environ Med 2003;45:369-78
23. Hauser SL, Longo DL, Jameson JL, editors. Harrison's principles of internal medicine. 15th edn. New York: McGraw-Hill, 2001
24. Elixhauser A, Steiner C, Palmer L. Clinical classifications software, 2004. US Agency for Healthcare Research and Quality. Available from http://www.hcup-us.ahrq.gov/reports/methods. jsp [Accessed 4 Nov 2004]
25. Bhugra D, Flick GR. Pathways to care for patients with bipolar disorder. Bipolar Disord 2005;7:236-45
26. Rush AJ. Toward an understanding of bipolar disorder and its origin. J Clin Psychiatry 2003;64(Suppl 6):4-8; discussion 28
27. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001;3:181-8
28. Nasrallah HA. Factors in antipsychotic drug selection: tolerability considerations. CNS Spect 2003;8:23-5
29. Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004;173:309-14
30. Kadam UT, Jordan K, Croft PR. Clinical comorbidity in patients with osteoarthritis: a case-control study of general practice consulters in England and Wales. Ann Rheum Dis 2004;63: 408-14
31. Kadam UT, Jordan K, Croft PR. Clinical comorbidity was specific to disease pathology, psychologic distress, and somatic symptom amplification. J Clin Epidemiology 2005;58:909-17
32. Hallner D, Hasenbring M. Classification of psychosocial risk factors (yellow flags) for the development of chronic low back and leg pain using artificial neural network. Neurosci Lett 2004;361:151-4
33. Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry 2003;60:1125-30
34. Jamison KR. Suicide and bipolar disorder. J Clin Psychiatry 2000;61(Suppl 9):47-51
35. Leverich GS, Altshuler LL, Frye MA, et al. Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network. J Clin Psychiatry 2003;64:506-15
36. Aro P, Ronkainen J, Talley NJ, et al. Body mass index and chronic unexplained gastrointestinal symptoms: an adult endoscopic population based study. Gut 2005;54:1377-83
37. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140-56
38. Wilcox CM, Alexander LN, Straub RF, et al. A prospective endoscopic evaluation of the causes of upper GI hemorrhage in alcoholics: a focus on alcoholic gastropathy. Am J Gastroenterol 1996;91:1343-7
39. Low NC, Du Fort GG, Cervantes P. Prevalence, clinical correlates, and treatment of migraine in bipolar disorder. Headache 2003;43:940-9
40. Markowitz GS, Radhakrishnan J, Kambham N, et al. Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 2000;11:1439-48
41. Post RM, Leverich GS, Altshuler LL, et al. An overview of recent findings of the Stanley Foundation Bipolar Network (Part I). Bipolar Disord 2003;5:310-9
42. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord 2004;6:368-73
43. Basu R, Brar JS, Chengappa KN, et al. The prevalence of the metabolic syndrome in patients with schizoaffective disorder - bipolar subtype. Bipolar Disord 2004;6:314-8
44. Narrow WE, Rae DS, Robins LN, et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates. Arch Gen Psychiatry 2002;59:115-23
45. Simon GE. Social and economic burden of mood disorders. Biol Psychiatry 2003;54:208-15